Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion

Neuroscience

Volumn 169, Issue 2, 2010, Pages 683-696

  Eftekhari, S ^a   Salvatore, C A ^b   Calamari, A ^b   Kane, S A ^b   Tajti, J ^c   Edvinsson, L ^a  

^a LUND UNIVERSITY   (Sweden)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Calcitonin receptor like receptor (CLR); Immunohistochemistry; Migraine; Receptor activity modifying protein 1 (RAMPz1); Trigeminocervical complex

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CELL COUNT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SATELLITE CELL; SIGNAL TRANSDUCTION; TRIGEMINUS GANGLION;

AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES; CALCITONIN GENE-RELATED PEPTIDE; CALCITONIN RECEPTOR-LIKE PROTEIN; CELL COUNT; CELL LINE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROGLIA; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; TRIGEMINAL GANGLION;

EID: 77954620156     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.05.016     Document Type: Article

References (52)

1. Bellamy J.L., Cady R.K., Durham P.L. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache 2006, 46:24-33.
2. Capuano A., De Corato A., Lisi L., Tringali G., Navarra P., Dello Russo C. Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol Pain 2009, 5:43.
3. Cottrell G.S., Roosterman D., Marvizon J.C., Song B., Wick E., Pikios S., Wong H., Berthelier C., Tang Y., Sternini C., Bunnett N.W., Grady E.F. Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat. J Comp Neurol 2005, 490:239-255.
4. Doods H., Arndt K., Rudolf K., Just S. CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci 2007, 28:580-587.
5. Dublin P., Hanani M. Satellite glial cells in sensory ganglia: their possible contribution to inflammatory pain. Brain Behav Immun 2007, 21:592-598.
6. Durham P.L. Calcitonin gene-related peptide (CGRP) and migraine. Headache 2006, 46(Suppl 1):S3-S8.
7. Durham P.L. Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine. Headache 2008, 48:1269-1275.
8. Edvinsson L. Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache. Cephalalgia 2004, 24:611-622.
9. Edvinsson L. CGRP blockers in migraine therapy: where do they act?. Br J Pharmacol 2008, 155:967-969.
10. Edvinsson L., Cantera L., Jansen-Olesen I., Uddman R. Expression of calcitonin gene-related peptide1 receptor mRNA in human trigeminal ganglia and cerebral arteries. Neurosci Lett 1997, 229:209-211.
11. Edvinsson L, Chan KY, Eftekhari S, Nilsson E, Vries R, Säveland H, Dirven C, Danser AH, MaassenVanDenBrink A (in press) Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries. Cephalalgia, in press.
12. Edvinsson L., Ekman R., Jansen I., McCulloch J., Uddman R. Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J Cereb Blood Flow Metab 1987, 7:720-728.
13. Edvinsson L., Linde M. New drugs in migraine treatment: telcagepant and topiramate. Lancet 2010, 375:1-11.
14. Edvinsson L., Mulder H., Goadsby P.J., Uddman R. Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. J Auton Nerv Syst 1998, 70:15-22.
15. Edvinsson L., Uddman R. Neurobiology in primary headaches. Brain Res Brain Res Rev 2005, 48:438-456.
16. Evans B.N., Rosenblatt M.I., Mnayer L.O., Oliver K.R., Dickerson I.M. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 2000, 275:31438-31443.
17. Foord S.M., Marshall F.H. RAMPs: accessory proteins for seven transmembrane domain receptors. Trends Pharmacol Sci 1999, 20:184-187.
18. Goadsby P.J. Migraine pathophysiology. Headache 2005, 45(Suppl 1):S14-S24.
19. Goadsby P.J., Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993, 33:48-56.
20. Goadsby P.J., Edvinsson L., Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 1988, 23:193-196.
21. Goadsby P.J., Edvinsson L., Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990, 28:183-187.
22. Gulbenkian S., Uddman R., Edvinsson L. Neuronal messengers in the human cerebral circulation. Peptides 2001, 22:995-1007.
23. Hanani M. Satellite glial cells in sensory ganglia: from form to function. Brain Res Brain Res Rev 2005, 48:457-476.
24. Hay D.L., Poyner D.R., Quirion R. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor. Pharmacol Rev 2008, 60:143-145. International Union of Pharmacology.
25. Ho T.W., Ferrari M.D., Dodick D.W., Galet V., Kost J., Fan X., Leibensperger H., Froman S., Assaid C., Lines C., Koppen H., Winner P.K. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet 2008, 372:2115-2123.
26. Ho T.W., Mannix L.K., Fan X., Assaid C., Furtek C., Jones C.J., Lines C.R., Rapoport A.M. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 2008, 70:1304-1312.
27. Hou M., Kanje M., Longmore J., Tajti J., Uddman R., Edvinsson L. 5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Brain Res 2001, 909:112-120.
28. Just S., Arndt K., Doods H. The role of CGRP and nicotinic receptors in centrally evoked facial blood flow changes. Neurosci Lett 2005, 381:120-124.
29. Krastev D., Paloff D., Hinova-Palova A., Ovtscharoff W. Light-microscopic structure of trigeminal ganglion in humans. J IMAB Book 2007, 1:111-113.
30. Lassen L.H., Haderslev P.A., Jacobsen V.B., Iversen H.K., Sperling B., Olesen J. CGRP may play a causative role in migraine. Cephalalgia 2002, 22:54-61.
31. Lennerz J.K., Ruhle V., Ceppa E.P., Neuhuber W.L., Bunnett N.W., Grady E.F., Messlinger K. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 2008, 507:1277-1299.
32. Li J., Vause C.V., Durham P.L. Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 2008, 1196:22-32.
33. Limmroth V., Katsarava Z., Liedert B., Guehring H., Schmitz K., Diener H.C., Michel M.C. An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system. Pain 2001, 92:101-106.
34. Liu Y., Broman J., Edvinsson L. Central projections of sensory innervation of the rat superior sagittal sinus. Neuroscience 2004, 129:431-437.
35. Liu Y., Broman J., Edvinsson L. Central projections of the sensory innervation of the rat middle meningeal artery. Brain Res 2008, 1208:103-110.
36. Lynch J., Regan C., Edvinsson L., Hargreaves R., Kane S. Comparison of the vasoconstrictor effects of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (MK-0974) and zolmitriptan in human isolated coronary arteries. J Cardiovasc Pharmacol 2010, 55:518-521.
37. Ma Q.P., Hill R., Sirinathsinghji D. Colocalization of CGRP with 5-HT1B/ 1D receptors and substance P in trigeminal ganglion neurons in rats. Eur J Neurosci 2001, 13:2099-2104.
38. Mallee J.J., Salvatore C.A., leBourdelles B., Oliver K.R., Longmore J., Koblan K.S., Kane S.A. Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J Biol Chem 2002, 277:14294-14298.
39. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998, 393:333-339.
40. Olesen J., Diener H.C., Husstedt I.W., Goadsby P.J., Hall D., Meier U., Pollentier S., Lesko L.M. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004, 350:1104-1110.
41. Oliver K.R., Wainwright A., Edvinsson L., Pickard J.D., Hill R.G. Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 2002, 22:620-629.
42. Paone D.V., Shaw A.W., Nguyen D.N., Burgey C.S., Deng J.Z., Kane S.A., Koblan K.S., Salvatore C.A., Mosser S.D., Johnston V.K., Wong B.K., Miller-Stein C.M., Hershey J.C., Graham S.L., Vacca J.P., Williams T.M. Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl) azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl) piperidine-1-carboxamide (MK-0974). J Med Chem 2007, 50:5564-5567.
43. Pietrobon D. Migraine: new molecular mechanisms. Neuroscientist 2005, 11:373-386.
44. Quartu M., Diaz G., Floris A., Lai M.L., Priestley J.V., Del Fiacco M. Calcitonin gene-related peptide in the human trigeminal sensory system at developmental and adult life stages: immunohistochemistry, neuronal morphometry and coexistence with substance P. J Chem Neuroanat 1992, 5:143-157.
45. Salvatore C.A., Hershey J.C., Corcoran H.A., Fay J.F., Johnston V.K., Moore E.L., Mosser S.D., Burgey C.S., Paone D.V., Shaw A.W., Graham S.L., Vacca J.P., Williams T.M., Koblan K.S., Kane S.A. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carbox amide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine. J Pharmacol Exp Ther 2008, 324:416-421.
46. Tajti J., Uddman R., Edvinsson L. Neuropeptide localization in the "migraine generator" region of the human brainstem. Cephalalgia 2001, 21:96-101.
47. Tajti J., Uddman R., Moller S., Sundler F., Edvinsson L. Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst 1999, 76:176-183.
48. Thalakoti S., Patil V.V., Damodaram S., Vause C.V., Langford L.E., Freeman S.E., Durham P.L. Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache 2007, 47:1008-1023. discussion 24-25.
49. Uddman R., Edvinsson L., Ekman R., Kingman T., McCulloch J. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 1985, 62:131-136.
50. Uddman R., Tajti J., Hou M., Sundler F., Edvinsson L. Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2. Cephalalgia 2002, 22:112-116.
51. Vause C.V., Durham P.L. CGRP stimulation of iNOS and NO release from trigeminal ganglion glial cells involves mitogen-activated protein kinase pathways. J Neurochem 2009, 110:811-821.
52. Zhang Z., Winborn C.S., Marquez de Prado B., Russo A.F. Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 2007, 27:2693-2703.